EA202091237A1 - Новые полиморфные формы тримебутина малеата, способ получения и применения - Google Patents

Новые полиморфные формы тримебутина малеата, способ получения и применения

Info

Publication number
EA202091237A1
EA202091237A1 EA202091237A EA202091237A EA202091237A1 EA 202091237 A1 EA202091237 A1 EA 202091237A1 EA 202091237 A EA202091237 A EA 202091237A EA 202091237 A EA202091237 A EA 202091237A EA 202091237 A1 EA202091237 A1 EA 202091237A1
Authority
EA
Eurasian Patent Office
Prior art keywords
polymorphic forms
obtaining
application
new polymorphic
trimebutin maleate
Prior art date
Application number
EA202091237A
Other languages
English (en)
Russian (ru)
Inventor
Кирилл Конста Сыров
Владимир Викторович НЕСТЕРУК
Original Assignee
Общество С Ограниченной Ответственностью "Валента-Интеллект"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66540370&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA202091237(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Общество С Ограниченной Ответственностью "Валента-Интеллект" filed Critical Общество С Ограниченной Ответственностью "Валента-Интеллект"
Publication of EA202091237A1 publication Critical patent/EA202091237A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/18Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA202091237A 2017-11-20 2018-11-08 Новые полиморфные формы тримебутина малеата, способ получения и применения EA202091237A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2017140269A RU2706166C2 (ru) 2017-11-20 2017-11-20 Новые полиморфные формы тримебутина малеата, способ получения и применения
PCT/RU2018/000729 WO2019098883A1 (ru) 2017-11-20 2018-11-08 Полиморфные формы тримебутина малеата и способ применения

Publications (1)

Publication Number Publication Date
EA202091237A1 true EA202091237A1 (ru) 2020-08-17

Family

ID=66540370

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091237A EA202091237A1 (ru) 2017-11-20 2018-11-08 Новые полиморфные формы тримебутина малеата, способ получения и применения

Country Status (7)

Country Link
KR (1) KR102509190B1 (ko)
CN (1) CN111432811B (ko)
BR (1) BR112020010135A2 (ko)
EA (1) EA202091237A1 (ko)
RU (1) RU2706166C2 (ko)
UA (1) UA124755C2 (ko)
WO (1) WO2019098883A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2752086C1 (ru) * 2020-04-27 2021-07-22 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новое соединение [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата 4-метил-2н-хромен-2-он-7-илсульфат и его применение

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2131804B1 (ko) * 1971-03-12 1974-03-22 Jouveinal Sa
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
CN102188389B (zh) * 2010-03-18 2014-04-02 杭州赛利药物研究所有限公司 马来酸曲美布汀干混悬剂及其制备方法
KR101220829B1 (ko) * 2010-07-16 2013-01-10 안국약품 주식회사 트리메부틴 함유 서방성 정제
EP2481403A1 (en) * 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Pharmaceutical combination of otilonium and trimebutine
MX2014010910A (es) * 2012-03-12 2015-03-09 Gicare Pharma Inc Sales novedosas de trimebutina basadas en sulfonato.

Also Published As

Publication number Publication date
RU2017140269A3 (ko) 2019-05-20
KR102509190B1 (ko) 2023-03-14
WO2019098883A1 (ru) 2019-05-23
UA124755C2 (uk) 2021-11-10
RU2017140269A (ru) 2019-05-20
KR20200110308A (ko) 2020-09-23
BR112020010135A2 (pt) 2021-03-23
CN111432811B (zh) 2023-06-23
CN111432811A (zh) 2020-07-17
RU2706166C2 (ru) 2019-11-14

Similar Documents

Publication Publication Date Title
EA201691974A1 (ru) Антитела против ox40 и способы их применения
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
EA201792590A1 (ru) КОНЪЮГАТ АНТИТЕЛА ПРОТИВ ErbB2 И ЛЕКАРСТВЕННОГО СРЕДСТВА И ЕГО КОМПОЗИЦИЯ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
EA201691582A1 (ru) Новые фармацевтические препараты
EA201691134A1 (ru) Новые ингибиторы глутаминазы
EA201790529A1 (ru) Новые антитела против mfi2 и способы их применения
EA201691541A1 (ru) Новые анти-baff антитела
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
CR20190387A (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos
EA201492282A1 (ru) Антагонистические антигенсвязывающие белки к двум рецепторам и их применение
EA202091337A1 (ru) Ингибиторы гистонацетилтрансфераз семейства myst
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
DK3744316T3 (da) Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf
EA201792262A1 (ru) Пироглутамат вортиоксетина
EA202091259A1 (ru) Способ получения опикапона и его интермедиатов
EA201790445A1 (ru) Производные индолинона и их применение
EA201890364A1 (ru) СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t
EA201992883A1 (ru) АНТИТЕЛА К TrkB
EA202091567A1 (ru) Химерные белки мти
EA201790699A1 (ru) Стабилизированные производные адреномедуллина и их применение
EA201790893A1 (ru) Способы лечения офтальмологических расстройств
EA201691493A1 (ru) Замещенные n-арилпиридиноны